How to Use the FORTA (“Fit fOR The Aged”) List to Improve Pharmacotherapy in the Elderly

Abstract

Background: Multimorbidity and polypharmacy are threats to elderly patients; improvement of medication is important and a novel listing approach (the FORTA list) should support this in clinical practice. Here we aim to describe procedural details of successful application of FORTA. FORTA labels range from A (indispensable), B (beneficial), C (questionable) to D (avoid), depending on evidence for safety, efficacy and overall age-appropriateness. As implicit tool it is only applicable if medical details of the patient are known; the drug selection process and secondary assessments are compiled into a manual for successful, embedded use of FORTA.

Discussion: A flow chart is developed for the complex process of medication in the elderly starting from history taking and diagnostic assessment including disease grading. This is the base for FORTA-assisted selection of drugs to avoid overtreatment (drug not necessary), undertreatment (condition not or not sufficiently treated by positively labeled drugs) or mistreatment (drugs indicated, but negatively rather than positively labeled drug chosen). Selection is followed by secondary analyses, e. g. regarding contraindications (e. g. allergies), former drug responses, interactions, route of application, duration and dosing (e. g. renal adaptation). This may lead to iterative process optimization. The medication scheme is updated in reflection of clinical effects (e. g. blood pressure) and side effects (e. g. dizziness).

Conclusion: The FORTA approach as an implicit tool should be embedded into the diagnostic and therapeutic workup of elderly patients and can give pivotal hints for the choice of medications; however it should not be seen as an isolated instrument.

Key words

polypharmacy - elderly - FORTA-list - implicit tool - positive list - negative list

• References

• 1 Kaufman DW, Kelly JP, Rosenberg L et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002; 287: 337-344
• 2 Mangoni AA. Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2003; 57: 6-14
• 3 Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-1259
• 4 Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. Br Med J 1997; 315: 1096-1099
• 5 Chyka PA. How many deaths occur annually from adverse drug reactions in the United States?. Am J Med 2000; 109: 122-130
• 6 Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205
• 7 Levy HB, Marcus EL, Christen C. Beyond the Beers Criteria: a comparative overview of explicit criteria. Ann Pharmacother 2010; 44: 1968-1975
• 8 Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An Update. Arch Intern Med 1997; 157: 1531-1536
• 9 Fick DM, Semla TP. American Geriatrics Society Beers Criteria: new year, new criteria, new perspective. J Am Geriatr Soc 2012; 60: 614-615
• 10 Page RL, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006; 4: 297-305
• 11 Gallagher P, Ryan C, Byrne S et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Consensus validation. Int J. Clin Pharmacol Ther 2008; 46: 72-83
• 12 Wehling M. Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged FORTA. Dtsch Med Wochenschr 2008; 133: 2289-2291 (in German)
• 13 Wehling M. Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the aged. J Am Geriatr Soc 2009; 57: 560-561
• 14 Barry PJ, Gallagher P Ryan et al. START-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 632-638
• 15 Kuhn-Thiel AM, Weiß C, Wehling M. The FORTA authors/expert panel members. Consensus validation of the FORTA (Fit fOR The Aged) list: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging 2014; 31: 131-140
• 16 Wehling M, Burkhardt H. Arzneitherapie für Ältere. 2^nd (ed.) Heidelberg: Springer; 2011. (in German)
• 17 Wehling M. Drug therapy for the elderly. Vienna: Springer Publishers; 2013
• 18 Michalek C, Wehling M, Schlitzer J et al. Effects of “Fit fOR The Aged” (FORTA) on pharmacotherapy and clinical endpoints-a pilot randomized controlled study. Eur J Clin Pharmacol 2014; 70: 1261-1267
• 19 Wehling M. Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients. J Am Geriatr Soc 2011; 59: 376-377
• 20 Doser S, Marz W, Reinecke MF et al. Recommendations for statin therapy in the elderly. Internist 2004; 45: 1053-1062
• 21 Sue Kirkman M, Briscoe VJ, Clark N et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012; 60: 2342-2356
• 22 Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000; 5: 224-237
• 23 Hanlon JT, Schmader KE, Samsa GP et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-1051
• 24 Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int 2012; 32: 1491-1502
• 25 Trivalle C, Cartier T, Verny C et al. IMEPAG GROUP . Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects. J Nutr Health Aging 2010; 14: 57-61
• 26 Frohnhofen H, Michalek C, Wehling M. Assessment of drug treatment in geriatrics with the new FORTA criteria – Preliminary clinical experience. Dtsch Med Wochenschr 2011; 136: 1417-1421 (in German)
• 27 American Geriatrics Society 2012 Beers Criteria Update Expert Panel . American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616-631
• 28 Schoen C, Osborn R, Huynh PT et al. On the front lines of care: primary care doctors’ office systems, experiences, and views in seven countries. Health Aff (Millwood) 2005; 25: w555-w571